×
CeriBell Price to Free Cash Flow Ratio 1971-1970 | CBLL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
CeriBell price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
View More
CeriBell Price to Free Cash Flow Ratio 1971-1970 | CBLL
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
PE Ratio
P/S Ratio
Price/Book Ratio
Price-FCF Ratio
Net Worth
CeriBell price to free cash flow ratio from 1971 to 1970. Price to free cash flow ratio can be defined as
Related Stocks
Company Name
Market
Cap
Abbott Laboratories (ABT)
$198.7B
Stryker (SYK)
$134.5B
Boston Scientific (BSX)
$124.8B
Medtronic (MDT)
$116.2B
EssilorLuxottica (ESLOY)
$108B
Lonza Group Ag (LZAGY)
$46.2B
Haleon (HLN)
$44.6B
ResMed (RMD)
$37.6B
Koninklijke Philips (PHG)
$29.8B
Terumo (TRUMY)
$28.5B
Zimmer Biomet Holdings (ZBH)
$20.8B
Baxter (BAX)
$18.4B
Insulet (PODD)
$16.4B
Smith & Nephew SNATS (SNN)
$12.4B
Bio-Rad Laboratories (BIO)
$8.9B
Demant (WILYY)
$8.5B
BellRing Brands (BRBR)
$8.3B
Lantheus Holdings (LNTH)
$7.7B
ICU Medical (ICUI)
$4.3B
Haemonetics (HAE)
$3.9B
Prestige Consumer Healthcare (PBH)
$3.6B
TG Therapeutics (TGTX)
$3.6B
Perrigo (PRGO)
$3.4B
Envista Holdings (NVST)
$3.2B
Neogen (NEOG)
$3B
GN Store Nord (GNNDY)
$2.9B
QuidelOrtho (QDEL)
$2.6B
Agios Pharmaceuticals (AGIO)
$2.6B
Green Thumb Industries (GTBIF)
$2.3B
Curaleaf Holdings (CURLF)
$2.2B